Neumora Therapeutics
MA - WatertownBiotechnology
Focus: Neumora Therapeutics is a precision medicine biotech focused on developing novel treatments for brain diseases, particularly neurology and psychiatry indications. The company operates as a pre-revenue stage biotech with a lean pipeline focused on CNS disorders.
Profile data last refreshed 1h ago · AI intelligence enriched 2mo ago
Open Jobs
2
Should You Work at Neumora Therapeutics?
AI assessmentNeumora is an early-stage precision medicine bet suitable for mission-driven scientists seeking meaningful CNS work, but with elevated risk around financing and company runway.
Why Work Here
- Lead a precision medicine platform in high-unmet-need CNS space with NMRA-335140 progressing through Phase 3 for Major Depressive Disorder
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Late-stage
4 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
NMRA-323511
Alzheimer's DiseaseClinical Trials (1)
NCT06546995Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease
Phase 1Help build intelligence for Neumora Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.